Cargando…
EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease
The therapeutic targeting of prostanoid subtype receptors may slow the development of chronic kidney disease (CKD) through mechanisms that are distinct from those of upstream COX inhibition. Here, employing multiple experimental models of CKD, we studied the effects of inhibition of the EP4 receptor...
Autores principales: | Thieme, Karina, Majumder, Syamantak, Brijmohan, Angela S., Batchu, Sri N., Bowskill, Bridgit B., Alghamdi, Tamadher A., Advani, Suzanne L., Kabir, M. Golam, Liu, Youan, Advani, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469816/ https://www.ncbi.nlm.nih.gov/pubmed/28611444 http://dx.doi.org/10.1038/s41598-017-03237-3 |
Ejemplares similares
-
HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease
por: Brijmohan, Angela S., et al.
Publicado: (2018) -
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans
por: Batchu, Sri Nagarjun, et al.
Publicado: (2020) -
Altered expression, but small contribution, of the histone demethylase KDM6A in obstructive uropathy in mice
por: Hong, Lisa Y. Q., et al.
Publicado: (2023) -
Early-Outgrowth Bone Marrow Cells Attenuate Renal Injury and Dysfunction via an Antioxidant Effect in a Mouse Model of Type 2 Diabetes
por: Zhang, Yanling, et al.
Publicado: (2012) -
Pressure overload induces ISG15 to facilitate adverse ventricular remodeling and promote heart failure
por: Yerra, Veera Ganesh, et al.
Publicado: (2023)